Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.

Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.

Item
http://www.wikidata.org/entity/Q33263841
Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin ZA p38 substrate-specific MK2-EGFP translocation assay for identification and validation of new p38 inhibitors in living cells: a comprising alternative for acquisition of cellular p38 inhibition dataHigh throughput toxicity screening and intracellular detection of nanomaterialsHCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell linesHigh-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.Development and validation of a high-content screening assay to identify inhibitors of cytoplasmic dynein-mediated transport of glucocorticoid receptor to the nucleus.Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.Using Caenorhabditis elegans to study serpinopathies.Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents.Moving to the core: spatiotemporal analysis of Forkhead box O (FOXO) and nuclear factor-κB (NF-κB) nuclear translocation.The development of high-content screening (HCS) technology and its importance to drug discovery.An overview of cell phenotypes in HCS: limitations and advantages.High Content Imaging Assays for IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines.High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions.
P2860

Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.

Item
http://www.wikidata.org/entity/Q33263841
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Assay development and case his ...... rrayScan 3.1 imaging platform.
@ast
Assay development and case his ...... rrayScan 3.1 imaging platform.
@en
Assay development and case his ...... rrayScan 3.1 imaging platform.
@nl
type
label
Assay development and case his ...... rrayScan 3.1 imaging platform.
@ast
Assay development and case his ...... rrayScan 3.1 imaging platform.
@en
Assay development and case his ...... rrayScan 3.1 imaging platform.
@nl
prefLabel
Assay development and case his ...... rrayScan 3.1 imaging platform.
@ast
Assay development and case his ...... rrayScan 3.1 imaging platform.
@en
Assay development and case his ...... rrayScan 3.1 imaging platform.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P478
P50
P577
P698
P921
P356
P1433
P1476
Assay development and case his ...... rrayScan 3.1 imaging platform.
@en
P2093
P304
P31
P356
10.1016/S0076-6879(06)14023-9
P407
P478
P50
P577
P698
P921